Cianfrocca Roberta, Tocci Piera, Rosanò Laura, Caprara Valentina, Sestito Rosanna, Di Castro Valeriana, Bagnato Anna
Translational Research Functional Departmental Area, Regina Elena National Cancer Institute, Rome, Italy.
Oncotarget. 2016 Apr 5;7(14):17790-804. doi: 10.18632/oncotarget.7461.
Hypoxia-inducible factor-1α (HIF-1α) mediates the response to hypoxia or other stimuli, such as growth factors, including endothelin-1 (ET-1), to promote malignant progression in numerous tumors. The importance of cofactors that regulate HIF-1α signalling within tumor is not well understood. Here we elucidate that ET-1/ET(A) receptor (ET(A)R)-induced pathway physically and functionally couples the scaffold protein β-arrestin1 (β-arr1) to HIF-1α signalling. In epithelial ovarian cancer (EOC) cells, ET-1/ET(A)R axis induced vascular-endothelial growth factor (VEGF) expression through HIF-1α nuclear accumulation. In these cells, activation of ET(A)R by ET-1, by mimicking hypoxia, promoted the nuclear interaction between β-arr1 and HIF-1α and the recruitment of p300 acetyltransferase to hypoxia response elements on the target gene promoters, resulting in enhanced histone acetylation, and HIF-1α target gene transcription. Indeed, β-arr1-HIF-1α interaction regulated the enhanced expression and release of downstream targets, such as ET-1 and VEGF, required for tumor cell invasion and pro-angiogenic effects in endothelial cells. These effects were abrogated by β-arr1 or HIF-1α silencing or by pharmacological treatment with the dual ET-1 receptor antagonist macitentan. Interestingly, ET(A)R/β-arr1 promoted the self-amplifying HIF-1α-mediated transcription of ET-1 that sustained a regulatory circuit involved in invasive and angiogenic behaviors. In a murine orthotopic model of metastatic human EOC, treatment with macitentan, or silencing of β-arr1, inhibits intravasation and metastasis formation. Collectively, these findings reveal the interplay of β-arr1 with HIF-1α in the complexity of ET-1/ET(A)R signalling, mediating epigenetic modifications directly involved in the metastatic process, and suggest that targeting ET-1-dependent β-arr1/HIF-1α pathway by using macitentan may impair EOC progression.
缺氧诱导因子-1α(HIF-1α)介导细胞对缺氧或其他刺激(如生长因子,包括内皮素-1(ET-1))的反应,以促进多种肿瘤的恶性进展。肿瘤内调节HIF-1α信号传导的辅助因子的重要性尚未得到充分了解。在此,我们阐明ET-1/ET(A)受体(ET(A)R)诱导的信号通路在物理和功能上将支架蛋白β-抑制蛋白1(β-arr1)与HIF-1α信号传导联系起来。在上皮性卵巢癌(EOC)细胞中,ET-1/ET(A)R轴通过HIF-1α核积累诱导血管内皮生长因子(VEGF)表达。在这些细胞中,ET-1激活ET(A)R,通过模拟缺氧,促进β-arr1与HIF-1α之间的核相互作用以及p300乙酰转移酶募集到靶基因启动子上的缺氧反应元件,导致组蛋白乙酰化增强以及HIF-1α靶基因转录。实际上,β-arr1-HIF-1α相互作用调节下游靶点(如ET-1和VEGF)的表达增强和释放,这些靶点是肿瘤细胞侵袭和内皮细胞促血管生成作用所必需的。β-arr1或HIF-1α沉默或用双重ET-1受体拮抗剂马昔腾坦进行药物治疗可消除这些作用。有趣的是,ET(A)R/β-arr1促进了ET-1的自扩增HIF-1α介导的转录,维持了一个涉及侵袭和血管生成行为的调节回路。在转移性人EOC的小鼠原位模型中,用马昔腾坦治疗或沉默β-arr1可抑制肿瘤细胞内渗和转移形成。总的来说,这些发现揭示了β-arr1与HIF-1α在ET-1/ET(A)R信号复杂性中的相互作用,介导了直接参与转移过程的表观遗传修饰,并表明使用马昔腾坦靶向ET-1依赖性β-arr1/HIF-1α途径可能会损害EOC的进展。